Product Program year 2025 Source: CMS Open Payments

Perclose Proglide

Device Structural Heart

PDI 08717648013089

Open in the dashboard

General payments

$251,746

1,403 payments

Research payments

$0

0 payments

Through program year 2025, $251,746 in general payments and $0 in research payments were reported against Perclose Proglide (Structural Heart).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $251,746 1,403

Breakdown

Who paid General payments · program year 2025
  1. Abbott Laboratories $251,746 1,403 payments
Top recipients General payments · program year 2025
  1. Mehran Massumi Interventional Cardiology · Houston, TX $19,477 8% · 15 payments
  2. Peter Faries Vascular Surgery · New York, NY $18,900 8% · 2 payments
  3. Sahil Parikh Interventional Cardiology · New York, NY $16,452 7% · 3 payments
  4. Prakash Krishnan Interventional Cardiology · New York, NY $11,376 5% · 29 payments
  5. Ajit Rao Vascular Surgery · New York, NY $7,677 3% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $97,337 40% · 81 practitioners
  2. Vascular Surgery Surgery $52,073 21% · 36 practitioners
  3. Cardiovascular Disease Internal Medicine $51,154 21% · 59 practitioners
  4. Vascular & Interventional Radiology Radiology $14,019 6% · 23 practitioners
  5. Clinical Cardiac Electrophysiology Internal Medicine $11,803 5% · 67 practitioners

The top 5 of 44 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $66,273 26% · 40 recipients
  2. Texas $44,276 18% · 64 recipients
  3. New Jersey $16,584 7% · 12 recipients
  4. Michigan $13,452 5% · 17 recipients
  5. Illinois $11,043 4% · 38 recipients

The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,403 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record